Nerivio received clearance in January 2021 for use in acute migraine.
Isabella Ciccone, MPH
Advertisement
Articles by Isabella Ciccone, MPH
Advertisement
Latest Updated Articles
FDA: Nerivio Cleared for Migraine PreventionPublished: March 2nd 2023 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacies Should Prioritize Medicare Transaction Facilitator Enrollment | NCPA 2025
2
COVID-19 Vaccination Benefits Patients With Systemic Lupus Erythematosus
3
FDA Releases Biosimilar Guidance Pushing to Streamline Development
4
General Awareness of PBM Practices Driving Optimism for Independent Pharmacies | NCPA 2025
5
